Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Columbia Care Inc.
  6. News
  7. Summary
    CCHW   CA1973091079

COLUMBIA CARE INC.

(CCHW)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Columbia Care : to Report Third Quarter 2021 Results on Friday, November 12, 2021

09/30/2021 | 06:18pm EST

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced that it will report its financial results for the third quarter ended September 30, 2021 before US financial markets open on Friday, November 12, 2021. Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EST to discuss financial and operating results for the third quarter of 2021.

Conference Call and Webcast Details

To access the live conference call via telephone, please dial 1-877-407-8914 (US Callers) or 1-201-493-6795 (international callers). A live audio webcast of the call will also be available in the Investor Relations section of the Company's website at https://ir.col-care.com/ or at https://78449.themediaframe.com/dataconf/productusers/colc/mediaframe/46646/indexl.html.

A replay of the audio webcast will be available in the Investor Relations section of the Company’s website approximately 2 hours after completion of the call and will be archived for 30 days.

About Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 130 facilities including 99 dispensaries and 31 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Plant Sugar, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.


© Business Wire 2021
All news about COLUMBIA CARE INC.
11/19Columbia Care is First U.S.-Based Cannabis Company to Win Platinum MarCom Award; Earns ..
BU
11/18Columbia Care Brings Iconic Heavyweight Champion Mike Tyson's Much-Anticipated Tyson 2...
BU
11/18Columbia Care Inc. to Launch Tyson 2.0 Cannabis Brand to Colorado
CI
11/12Columbia Care Inc. Revises Earnings Guidance for the Year of 2021
CI
11/12Columbia Care Reports Record Third Quarter 2021 Results
BU
11/12Columbia Care Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended..
CI
11/08Columbia Care Inc. Opens Third Dispensary At 11190 West Broad Street in Glen Allen, Vir..
CI
11/01Columbia Care Completes Acquisition of Colorado-Based Medicine Man; Strengthens Leaders..
BU
11/01Columbia Care Inc. completed the acquisition of Medicine Man of Denver, Inc.
CI
10/27Tyson 2.0 Announces Partnership to Launch Portfolio of Tyson Branded Cannabis Products ..
CI
More news
Financials (USD)
Sales 2021 475 M - -
Net income 2021 -67,3 M - -
Net Debt 2021 387 M - -
P/E ratio 2021 -16,8x
Yield 2021 -
Capitalization 5 705 M 5 710 M -
EV / Sales 2021 12,8x
EV / Sales 2022 8,16x
Nbr of Employees -
Free-Float 58,6%
Chart COLUMBIA CARE INC.
Duration : Period :
Columbia Care Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 3,11 $
Average target price 10,72 $
Spread / Average Target 245%
EPS Revisions
Managers and Directors
Nicholas Keane Vita Vice Chairman & Chief Executive Officer
Michael Livingstone Chief Financial Officer, VP & Controller
Michael Abbott Executive Chairman
Rosemary Mazanet Chief Scientific Officer
David James Hart Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
COLUMBIA CARE INC.-48.51%5 710
HARVEST HEALTH & RECREATION INC.42.91%1 363
AYR WELLNESS INC.-24.30%1 206
ORGANIGRAM HOLDINGS INC.59.76%633
CANSORTIUM INC.-2.63%186
RUBICON ORGANICS INC.-40.33%95